Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPID | Q08752 | 2/20 | 0.58 |
| ▸ | PPIB | P23284 | 1/20 | 0.58 |
| ▸ | PPIA | P62937 | 1/20 | 0.58 |
| ▸ | PPIG | Q13427 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL77910 | 0.98 | PPIB (0.56) | PPIDPPIBPPIAPPIGLMNA | |
| SCHEMBL68851 | 0.90 | CYP4Z1 (0.62) | LMNACYP4Z1MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL10461745 | 0.85 | CYP4F2 (0.53) | PPIDPPIBPPIAPPIGLMNA | |
| SCHEMBL11038201 | 0.85 | CYP1A2 (0.47) | PPIDPPIBPPIAPPIGLMNA | |
| SCHEMBL19346039 | 0.85 | LMNA (0.48) | PPIDPPIBPPIAPPIGLMNA | |
| SCHEMBL480039 | 0.85 | CYP4Z1 (0.54) | LMNACYP1A2CYP4Z1MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL27427984 | 0.84 | LMNA (0.49) | PPIDPPIBPPIAPPIGLMNA | |
| SCHEMBL10299459 | 0.84 | CYP4Z1 (0.57) | LMNACYP4Z1MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL6057577 | 0.84 | CYP4F2 (0.59) | LMNACYP4Z1MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL1107146 | 0.84 | CYP4Z1 (0.57) | LMNACYP1A2CYP4Z1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1026 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613279-A | N-substituted benzene ring bioisostere and preparation method thereof | 上海交通大学 | 2025-03-14 | — | — | CN | claimed |
| CN-118955358-A | FXR partial agonist containing piperidine structure, and preparation method and application thereof | 桂林医学院 | 2024-11-15 | — | — | CN | claimed |
| CN-114736159-B | Photo-crosslinking molecular probe and preparation method and application thereof | 南京医科大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117551311-A | Composite cable | 顺磊线缆有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-117285504-A | Amino phenylacetamide derivative and preparation method and application thereof | 桂林医学院 | 2023-12-26 | — | — | CN | claimed |
| CN-114736159-A | Photo-crosslinking molecular probe and preparation method and application thereof | 南京医科大学 | 2022-07-12 | — | — | CN | claimed |
| JP-58194814-A | — | — | None | — | — | JP | disclosed |
| US-20260083723-A1 | THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS | TORAY INDUSTRIES, INC. (JP) | 2026-03-26 | — | — | US | disclosed |
| US-12570639-B2 | Tetrahydroquinoline derivative and medicinal use thereof | TORAY INDUSTRIES, INC. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20260008788-A1 | AZA-FUSED RING COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE | SUZHOU ARK BIOPHARMACEUTICAL CO LTD (CN) | 2026-01-08 | — | — | US | disclosed |
| EP-4673450-A1 | TETRAHYDROQUINOLINE DERIVATIVES FOR INHIBITING CAV3.2-USP5 INTERACTIONS | Zymedyne Therapeutics Inc. (CA) | 2026-01-07 | — | — | EP | disclosed |
| EP-4674852-A1 | PREPARATION METHOD FOR AND USE OF DIHYDROTHIENOPYRIMIDINE DERIVATIVE | Innovstone Therapeutics Limited (CN) | 2026-01-07 | — | — | EP | disclosed |
| CN-120921764-B | Fireproof heat insulation plate and preparation method thereof | 河北国美新型建材有限公司 | 2025-12-16 | — | — | CN | disclosed |
| US-4163788-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1979-08-07 | — | — | US | disclosed |
| US-4138570-A | METHINE DYE | BAYER AKTIENGESELLSCHAFT (DE) | 1979-02-06 | — | — | US | disclosed |
| US-4126691-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1978-11-21 | — | — | US | disclosed |
| US-3997669-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1976-12-14 | — | — | US | disclosed |
| US-3993763-A | ALPHA-(CYCLIC TERTIARY AMINO-PHENYL)-ALIPHATIC ACIDS | CIBA-GEIGY CORPORATION (US) | 1976-11-23 | — | — | US | disclosed |
| US-3957850-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | BOUCHARA EMILE | 1976-05-18 | — | — | US | disclosed |
| US-3936467-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083723-A1 | THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS | AIFM2, GPX1, SOD1 | PPID 3563/4885PPIB 2815/4885PPIA 3805/4885 |
| US-20260008788-A1 | AZA-FUSED RING COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE | PDE4B, PDE4A, CYP4A11 | PPID 1533/4885PPIB 2801/4885PPIA 3080/4885 |
| US-12570639-B2 | Tetrahydroquinoline derivative and medicinal use thereof | AIFM2, GPX1, GPX4 | PPID 3175/4885PPIB 2856/4885PPIA 3581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.